Cases & Deals

JumpStart invests in SironRX Therapeutics

Clients JumpStart Inc.

Jones Day advised JumpStart Inc. in connection with its purchase of a Secured Convertible Promissory Note in a private placement by SironRX Therapeutics, Inc., a start-up company developing an SDF-1 treatment to induce vascular and epithelial regeneration in sternotomy wounds.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.